logo
Biobanking past, present and future
Longitudinal analysis of an HLA-B*51-restricted epitope in integrase reveals immune escape in early HIV-1 infection
HIV infection deregulates innate immunity to malaria despite combination antiretroviral therapy
Coverage of primary mother-to-child HIV transmission isolates by second-generation broadly neutralizing antibodies
Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders
Does pregnancy affect the early response to cART?
Efficacy and immunogenicity of influenza vaccine in HIV-infected children
Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals
Cognitive disorders in HIV-infected patients
Lack of regression of anal squamous intraepithelial lesions despite immune restoration under cART
Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events
Male sex and the risk of mortality among individuals enrolled in antiretroviral therapy programs in Africa
HIV among MSM in a large middle-income country
High HIV-1 incidence, correlates of HIV-1 acquisition, and high viral loads following seroconversion among MSM
The new role of antiretrovirals in combination HIV prevention
Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals
Markers of microbial translocation and risk of AIDS-related lymphoma
Mathematical modelling of HIV prevention intervention
Microbial translocation and AIDS-associated lymphomas
Tenofovir-associated proteinuria
No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patients
The safety of flucloxacillin in HIV-infected patients with positive HLA-B*5701 genotype
Immune reconstitution hepatitis E
Cryptococcal IRIS in the anterior segment of the eye
HLA-B*5701 and flucloxacillin associated drug-induced liver disease